Ethic Inc. Jazz Pharmaceuticals PLC Transaction History

Ethic Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$114.26 - $136.0 $48,674 - $57,936	426 Added 13.19%	3,656 $449,000
Q3 2023 Nov 14, 2023	BUY	$122.0 - $145.31 $160,918 - $191,663	1,319 Added 69.02%	3,230 $418,000
Q2 2023 Aug 14, 2023	BUY	$122.5 - $147.16 $66,517 - $79,907	543 Added 39.69%	1,911 $236,000
Q1 2023 May 12, 2023	BUY	$133.98 - $160.47 $183,284 - $219,522	1,368 New	1,368 $200,000

511

57.8M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.63B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

Stay updated on Ethic Inc. with notifications on news.